Related Experiment Videos
Growth Fraction of Human Tumors: Assays and Complications
Seminars in Radiation Oncology
|April 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
What determines the outcome after total mesorectal excision for rectal carcinoma-15 years experience of a specialist surgical unit.
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2013
Rabies.
Current treatment options in neurology·2000
Partitioning composite finite systems
Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics·2000
Drug-excipient interactions and their affect on absorption.
Pharmaceutical science & technology today·2000
Lattice-switch monte carlo method
Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics·2000
Growth and tissue composition as a function of feeding history in juvenile cephalopods.
Journal of experimental marine biology and ecology·2000
Resilience to Disaster: System Design and Future Directions.
Seminars in radiation oncology·2026
An Ethical Framework to Guide Radiation Therapy Treatment Modification in a Crisis.
Seminars in radiation oncology·2026
MRI Safety and Disaster Management for MR-Simulator and MR-Linacs.
Seminars in radiation oncology·2026
Emergency Preparedness for External Beam Radiotherapy Machines: Treatment Continuity and Interruption Recovery in Radiation Oncology.
Seminars in radiation oncology·2026
System Design for Robust Business Continuity in Radiotherapy.
Seminars in radiation oncology·2026
In Utero Alcohol Exposure Reprograms Mammary Gland Development and Stem/Progenitor Cell Activity in a Non-Tumorigenic Mouse Model.
bioRxiv : the preprint server for biology·2026
Cumulative expression of the two Lyn isoforms creates a threshold for macrophage signaling in the absence of receptor engagement.
Journal of leukocyte biology·2026
Retained epcoritamab activity despite routine CD20 assay negativity approximately one terminal half-life after mosunetuzumab in B-cell lymphoma.
Journal of clinical and experimental hematopathology : JCEH·2026